(3aR,9aR)-Fluparoxan is a chemical compound classified as a selective antagonist of the serotonin 5-HT1A receptor, which plays a significant role in various neurological processes. This compound is notable for its potential applications in the treatment of mood disorders and anxiety, as it modulates serotonin levels in the brain. Structurally, it features a complex bicyclic framework that contributes to its pharmacological properties. The stereochemistry indicated by the (3aR,9aR) designation suggests specific spatial arrangements of its atoms, which are crucial for its biological activity. Fluparoxan has been studied for its effects on neurotransmitter systems, particularly in relation to its anxiolytic and antidepressant-like effects in preclinical models. Additionally, its unique properties may offer insights into the development of new therapeutic agents targeting serotonin receptors. As with many pharmacologically active compounds, understanding its mechanism of action and potential side effects is essential for evaluating its therapeutic viability.

(3aR,9aR)-Fluparoxan

105182-47-6: (3aR,9aR)-Fluparoxan is a chemical compound classified as a selective antagonist of the serotonin 5-HT1A receptor, which plays a significant role in various neurological processes. This compound is notable for its potential applications in the treatment of mood disorders and anxiety, as it modulates serotonin levels in the brain. Structurally, it features a complex bicyclic framework that contributes to its pharmacological properties. The stereochemistry indicated by the (3aR,9aR) designation suggests specific spatial arrangements of its atoms, which are crucial for its biological activity. Fluparoxan has been studied for its effects on neurotransmitter systems, particularly in relation to its anxiolytic and antidepressant-like effects in preclinical models. Additionally, its unique properties may offer insights into the development of new therapeutic agents targeting serotonin receptors. As with many pharmacologically active compounds, understanding its mechanism of action and potential side effects is essential for evaluating its therapeutic viability.

<p>(3aR,9aR)-Fluparoxan is a highly selective and potent adrenergic receptor α2B antagonist for the prevention, amelioration or treatment of neurodevelopmental</p>

CAS 105182-47-6

(3aR,9aR)-Fluparoxan

(3aR,9aR)-Fluparoxan

Ref: TM-T77566

(3aR,9aR)-Fluparoxan

Ref: 54-BUP09416